Literature DB >> 26122249

PPI-Refractory GERD: an Intriguing, Probably Overestimated, Phenomenon.

Fabio Baldi1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26122249     DOI: 10.1007/s11894-015-0451-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


× No keyword cloud information.
  10 in total

Review 1.  Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.

Authors:  Daniel Sifrim; Frank Zerbib
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

2.  Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.

Authors:  John M Inadomi; Lisa McIntyre; Latoya Bernard; A Mark Fendrick
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

3.  Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?

Authors:  Gerrit J M Hemmink; Albert J Bredenoord; Bas L A M Weusten; Jan F Monkelbaan; Robin Timmer; André J P M Smout
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

4.  Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.

Authors:  R Carlsson; J Dent; R Watts; S Riley; R Sheikh; J Hatlebakk; K Haug; G de Groot; A van Oudvorst; A Dalväg; O Junghard; I Wiklund
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-02       Impact factor: 2.566

Review 5.  Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?

Authors:  Peter J Kahrilas; Guy Boeckxstaens
Journal:  Gut       Date:  2012-06-08       Impact factor: 23.059

6.  Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study.

Authors:  Diego García-Compeán; José Alberto González González; César Antonio Marrufo García; Juan Pablo Flores Gutiérrez; Oralia Barboza Quintana; Gabriela Galindo Rodríguez; Miguel Angel Mar Ruiz; David de León Valdez; Joel Omar Jaquez Quintana; Héctor Jesús Maldonado Garza
Journal:  Dig Liver Dis       Date:  2010-09-16       Impact factor: 4.088

7.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

8.  Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.

Authors:  Frank Zerbib; Sabine Roman; Alain Ropert; Stanislas Bruley des Varannes; Philippe Pouderoux; Ulriikka Chaput; François Mion; Eric Vérin; Jean-Paul Galmiche; Daniel Sifrim
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

9.  Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.

Authors:  Choo Hean Poh; Anita Gasiorowska; Tomas Navarro-Rodriguez; Marcia R Willis; Deborah Hargadon; North Noelck; Jane Mohler; Christopher S Wendel; Ronnie Fass
Journal:  Gastrointest Endosc       Date:  2010-01       Impact factor: 9.427

10.  Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.

Authors:  I Mainie; R Tutuian; S Shay; M Vela; X Zhang; D Sifrim; D O Castell
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

  10 in total
  2 in total

1.  Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.

Authors:  Rena Yadlapati; Michael F Vaezi; Marcelo F Vela; Stuart J Spechler; Nicholas J Shaheen; Joel Richter; Brian E Lacy; David Katzka; Philip O Katz; Peter J Kahrilas; Prakash C Gyawali; Lauren Gerson; Ronnie Fass; Donald O Castell; Jenna Craft; Luke Hillman; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2018-04-24       Impact factor: 10.864

2.  Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model.

Authors:  Roberta Salaroli; Domenico Ventrella; Chiara Bernardini; Alberto Elmi; Augusta Zannoni; Maria Laura Bacci; Monica Forni; Fiorella Calanni; Antonella Ferrieri; Fabio Baldi
Journal:  Clin Exp Gastroenterol       Date:  2020-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.